<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1000"/><api:result><api:object category="publication" id="1000" last-affected-when="2024-03-14T05:42:46.73+00:00" last-modified-when="2024-03-14T05:42:46.73+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1000" created-when="2010-05-17T13:47:29.28+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2000-05-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="95745" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033935816" last-modified-when="2020-06-23T20:37:02.59+01:00"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Background and Objectives. As a single gene defect in mature bone marrow cells, chronic granulomatous disease (X-CGD) represents a disorder which may be amenable to gene therapy by the transfer of the missing subunit into hemopoietic stem cells. In the majority of cases lack of Gp91-phox causes the disease. So far, studies involving transfer of Gp91-phox cDNA, including a phase I clinical trial, have yielded disappointing results. Most often, low titers of virus have been reported. In the present study we investigated the possible reasons for low titer amphotropic viral production. Design and Methods. To investigate the effect of Gp91 cDNA on the efficiency of retroviral production from the packaging cell line, GP+envAm12, we constructed vectors containing either the native cDNA, truncated versions of the cDNA or a mutated form (LATG) in which the natural translational start codon was changed to a stop codon. Following derivation of clonal packaging cell lines, these were assessed for viral titer by RNA slot blot and analyzed by nonparametrical statistical analysis (Whitney-Mann U-test). Results. An improvement in viral titer of just over two-fold was found in packaging cells containing the start-codon mutant of Gp91 and no evidence of truncated viral RNA was seen in these cells. Further analysis revealed the presence of rearranged forms of the provirus in Gp91-expressing cells, and the production of truncated, unpackaged viral RNA. Protein analysis revealed that LATG- transduced cells did not express full-length Gp91-phox, whereas those containing the wild-type cDNA did. However, a truncated protein was seen in ATG-transduced cells which was also present in wild type cells. No evidence for the presence of a negative transcriptional regulatory element was found from studies with the deletion mutants. Interpretation and Conclusions. A statistically significant effect of protein production on the production of virus from Gp91-expressing cells was found. Our data point to a need to restrict expression of the Gp91-phox protein and its derivatives in order to enhance retroviral production and suggest that improvements in current vectors for CGD gene therapy may need to include controlled, directed expression only in mature neutrophils. (C) 2000, Ferrata Storti Foundation.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="3353" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/3353"/></api:links><api:last-name>Bellantuono</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie NHS Foundation Trust</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Hammersmith Hospital</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57203608545</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lashford</api:last-name><api:initials>LS</api:initials><api:first-names>LS</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie NHS Foundation Trust</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7003729665</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rafferty</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie NHS Foundation Trust</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">24299318900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Fairbairn</api:last-name><api:initials>LJ</api:initials><api:first-names>LJ</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie NHS Foundation Trust</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7003757843</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10800158</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0390-6078</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/955541"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Haematologica</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>451</api:begin-page><api:end-page>457</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>85</api:text></api:field></api:native></api:record><api:record format="native" id="1000" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10800158" last-modified-when="2020-04-29T04:26:57.327+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>BACKGROUND AND OBJECTIVE: As a single gene defect in mature bone marrow cells, chronic granulomatous disease (X-CGD) represents a disorder which may be amenable to gene therapy by the transfer of the missing subunit into hemopoietic stem cells. In the majority of cases lack of Gp91-phox causes the disease. So far, studies involving transfer of Gp91-phox cDNA, including a phase I clinical trial, have yielded disappointing results. Most often, low titers of virus have been reported. In the present study we investigated the possible reasons for low titer amphotropic viral production. DESIGN AND METHODS: To investigate the effect of Gp91 cDNA on the efficiency of retroviral production from the packaging cell line, GP+envAm12, we constructed vectors containing either the native cDNA, truncated versions of the cDNA or a mutated form (LATG) in which the natural translational start codon was changed to a stop codon. Following derivation of clonal packaging cell lines, these were assessed for viral titer by RNA slot blot and analyzed by non-parametrical statistical analysis (Whitney-Mann U-test). RESULTS: An improvement in viral titer of just over two-fold was found in packaging cells containing the start-codon mutant of Gp91 and no evidence of truncated viral RNA was seen in these cells. Further analysis revealed the presence of rearranged forms of the provirus in Gp91-expressing cells, and the production of truncated, unpackaged viral RNA. Protein analysis revealed that LATG-transduced cells did not express full-length Gp91-phox, whereas those containing the wild-type cDNA did. However, a truncated protein was seen in ATG-transduced cells which was also present in wild type cells. No evidence for the presence of a negative transcriptional regulatory element was found from studies with the deletion mutants. INTERPRETATION AND CONCLUSIONS: A statistically significant effect of protein production on the production of virus from Gp91-expressing cells was found. Our data point to a need to restrict expression of the Gp91-phox protein and its derivatives in order to enhance retroviral production and suggest that improvements in current vectors for CGD gene therapy may need to include controlled, directed expression only in mature neutrophils.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="3353" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/3353"/></api:links><api:last-name>Bellantuono</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Immunology, Imperial College School of Medicine, The Hammersmith Hospital, Du Cane Road, London, W12 0NN, United Kingdom. i.bellantuono@ic.ac.uk</api:line></api:address></api:addresses><api:email-address>i.bellantuono@ic.ac.uk</api:email-address></api:person><api:person><api:last-name>Lashford</api:last-name><api:initials>LS</api:initials><api:first-names>LS</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rafferty</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Fairbairn</api:last-name><api:initials>LJ</api:initials><api:first-names>LJ</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10800158</api:text></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0390-6078</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/955541"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Haematologica</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">3T3 Cells</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Blotting, Northern</api:keyword><api:keyword scheme="mesh">Blotting, Southern</api:keyword><api:keyword scheme="mesh">Blotting, Western</api:keyword><api:keyword scheme="mesh">DNA, Complementary</api:keyword><api:keyword scheme="mesh">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh">Genetic Vectors</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">NADPH Oxidase 2</api:keyword><api:keyword scheme="mesh">NADPH Oxidases</api:keyword><api:keyword scheme="mesh">RNA, Viral</api:keyword><api:keyword scheme="mesh">Retroviridae</api:keyword><api:keyword scheme="mesh">Viral Proteins</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>Italy</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>451</api:begin-page><api:end-page>457</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>30</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>85</api:text></api:field></api:native></api:record><api:record format="native" id="882181" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10800158" last-modified-when="2021-01-19T17:57:08.05+00:00"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;h4&gt;Background and objective&lt;/h4&gt;As a single gene defect in mature bone marrow cells, chronic granulomatous disease (X-CGD) represents a disorder which may be amenable to gene therapy by the transfer of the missing subunit into hemopoietic stem cells. In the majority of cases lack of Gp91-phox causes the disease. So far, studies involving transfer of Gp91-phox cDNA, including a phase I clinical trial, have yielded disappointing results. Most often, low titers of virus have been reported. In the present study we investigated the possible reasons for low titer amphotropic viral production.&lt;h4&gt;Design and methods&lt;/h4&gt;To investigate the effect of Gp91 cDNA on the efficiency of retroviral production from the packaging cell line, GP+envAm12, we constructed vectors containing either the native cDNA, truncated versions of the cDNA or a mutated form (LATG) in which the natural translational start codon was changed to a stop codon. Following derivation of clonal packaging cell lines, these were assessed for viral titer by RNA slot blot and analyzed by non-parametrical statistical analysis (Whitney-Mann U-test).&lt;h4&gt;Results&lt;/h4&gt;An improvement in viral titer of just over two-fold was found in packaging cells containing the start-codon mutant of Gp91 and no evidence of truncated viral RNA was seen in these cells. Further analysis revealed the presence of rearranged forms of the provirus in Gp91-expressing cells, and the production of truncated, unpackaged viral RNA. Protein analysis revealed that LATG-transduced cells did not express full-length Gp91-phox, whereas those containing the wild-type cDNA did. However, a truncated protein was seen in ATG-transduced cells which was also present in wild type cells. No evidence for the presence of a negative transcriptional regulatory element was found from studies with the deletion mutants.&lt;h4&gt;Interpretation and conclusions&lt;/h4&gt;A statistically significant effect of protein production on the production of virus from Gp91-expressing cells was found. Our data point to a need to restrict expression of the Gp91-phox protein and its derivatives in order to enhance retroviral production and suggest that improvements in current vectors for CGD gene therapy may need to include controlled, directed expression only in mature neutrophils.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Immunology, Imperial College School of Medicine, The Hammersmith Hospital, Du Cane Road, London, W12 0NN, United Kingdom. i.bellantuono@ic.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="3353" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/3353"/></api:links><api:last-name>Bellantuono</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0001-9994-6987</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lashford</api:last-name><api:initials>LS</api:initials><api:first-names>LS</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rafferty</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Fairbairn</api:last-name><api:initials>LJ</api:initials><api:first-names>LJ</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1592-8721</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/955541"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10800158</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0390-6078</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/955541"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Haematologica</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">3T3 Cells</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Retroviridae</api:keyword><api:keyword scheme="mesh">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh">Viral Proteins</api:keyword><api:keyword scheme="mesh">DNA, Complementary</api:keyword><api:keyword scheme="mesh">RNA, Viral</api:keyword><api:keyword scheme="mesh">Blotting, Western</api:keyword><api:keyword scheme="mesh">Blotting, Northern</api:keyword><api:keyword scheme="mesh">Blotting, Southern</api:keyword><api:keyword scheme="mesh">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh">Genetic Vectors</api:keyword><api:keyword scheme="mesh">NADPH Oxidase 2</api:keyword><api:keyword scheme="mesh">NADPH Oxidases</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>451</api:begin-page><api:end-page>457</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>9</api:day><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>85</api:text></api:field></api:native></api:record><api:record format="native" id="2476819" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1074636068" last-modified-when="2023-11-27T00:41:42.82+00:00"><api:citation-count>0</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="3353" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/3353"/></api:links><api:last-name>Bellantuono</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Imperial College London</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Hammersmith Hospital</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01075025054.93</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lashford</api:last-name><api:initials>LS</api:initials><api:first-names>LS</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>S</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01177232305.95</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rafferty</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01330151172.12</api:identifier></api:identifiers></api:person><api:person><api:last-name>Fairbairn</api:last-name><api:initials>LJ</api:initials><api:first-names>LJ</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.016667014644.98</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10800158</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>0</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1466-4860</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/985084"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Haematologica</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3206 Medical Biotechnology</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Genetics</api:keyword><api:keyword scheme="rcdc">Gene Therapy</api:keyword><api:keyword scheme="rcdc">Biotechnology</api:keyword><api:keyword scheme="mesh">3T3 Cells</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Blotting, Northern</api:keyword><api:keyword scheme="mesh">Blotting, Southern</api:keyword><api:keyword scheme="mesh">Blotting, Western</api:keyword><api:keyword scheme="mesh">DNA, Complementary</api:keyword><api:keyword scheme="mesh">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh">Genetic Vectors</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">NADPH Oxidase 2</api:keyword><api:keyword scheme="mesh">NADPH Oxidases</api:keyword><api:keyword scheme="mesh">RNA, Viral</api:keyword><api:keyword scheme="mesh">Retroviridae</api:keyword><api:keyword scheme="mesh">Viral Proteins</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Gold OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>451</api:begin-page><api:end-page>457</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production.</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>85</api:text></api:field></api:native></api:record><api:record format="native" id="241532" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000087101100003" last-modified-when="2024-03-14T05:42:46.737+00:00"><api:citation-count>1</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="3353" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/3353"/></api:links><api:last-name>Bellantuono</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lashford</api:last-name><api:initials>LS</api:initials><api:first-names>LS</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rafferty</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Fairbairn</api:last-name><api:initials>LJ</api:initials><api:first-names>LJ</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000087101100003&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">315FC</api:identifier><api:identifier scheme="pubmed">10800158</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0390-6078</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/955541"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>HAEMATOLOGICA</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>CGD</api:keyword><api:keyword>G-91-phox</api:keyword><api:keyword>retroviral vector</api:keyword><api:keyword>gene therapy</api:keyword><api:keyword>immunodeficiencies</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>451</api:begin-page><api:end-page>457</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>The expression of full length Gp91-Phox protein is associated with reduced amphotropic retroviral production</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>85</api:text></api:field></api:native></api:record><api:record format="native" id="24652" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000087101100003" last-modified-when="2014-07-25T11:06:54.043+01:00"><api:citation-count>0</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="3353" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/3353"/></api:links><api:last-name>Bellantuono</api:last-name><api:initials>I</api:initials><api:first-names>I</api:first-names><api:separate-first-names><api:first-name>I</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Lashford</api:last-name><api:initials>LS</api:initials><api:first-names>LS</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Rafferty</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Fairbairn</api:last-name><api:initials>LJ</api:initials><api:first-names>LJ</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0390-6078</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/955541"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>HAEMATOLOGICA</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>CGD</api:keyword><api:keyword>G-91-phox</api:keyword><api:keyword>retroviral vector</api:keyword><api:keyword>gene therapy</api:keyword><api:keyword>immunodeficiencies</api:keyword><api:keyword>CHRONIC GRANULOMATOUS-DISEASE</api:keyword><api:keyword>GENE-TRANSFER</api:keyword><api:keyword>BONE-MARROW</api:keyword><api:keyword>MEDIATED EXPRESSION</api:keyword><api:keyword>NADPH OXIDASE</api:keyword><api:keyword>CELLS</api:keyword><api:keyword>RECONSTITUTION</api:keyword><api:keyword>ELEMENTS</api:keyword><api:keyword>VECTORS</api:keyword><api:keyword>REGION</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>451</api:begin-page><api:end-page>457</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>5</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The expression of full length Gp91-Phox protein is associated with reduced amphotropic retroviral production</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>85</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">3T3 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Blotting, Northern</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Blotting, Southern</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Blotting, Western</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">DNA, Complementary</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Genetic Vectors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">NADPH Oxidase 2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">NADPH Oxidases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">RNA, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Retroviridae</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Viral Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">3T3 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Retroviridae</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Viral Proteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">DNA, Complementary</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">RNA, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Blotting, Western</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Blotting, Northern</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Blotting, Southern</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Genetic Vectors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">NADPH Oxidase 2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">NADPH Oxidases</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3206 Medical Biotechnology</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Genetics</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Gene Therapy</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Biotechnology</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">3T3 Cells</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Animals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Blotting, Northern</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Blotting, Southern</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Blotting, Western</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">DNA, Complementary</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Gene Transfer Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Genetic Vectors</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Mice</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">NADPH Oxidase 2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">NADPH Oxidases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">RNA, Viral</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Retroviridae</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Viral Proteins</api:keyword><api:keyword origin="record-data" source="wos-lite">CGD</api:keyword><api:keyword origin="record-data" source="wos-lite">G-91-phox</api:keyword><api:keyword origin="record-data" source="wos-lite">retroviral vector</api:keyword><api:keyword origin="record-data" source="wos-lite">gene therapy</api:keyword><api:keyword origin="record-data" source="wos-lite">immunodeficiencies</api:keyword><api:keyword origin="record-data" source="wos">CGD</api:keyword><api:keyword origin="record-data" source="wos">G-91-phox</api:keyword><api:keyword origin="record-data" source="wos">retroviral vector</api:keyword><api:keyword origin="record-data" source="wos">gene therapy</api:keyword><api:keyword origin="record-data" source="wos">immunodeficiencies</api:keyword><api:keyword origin="record-data" source="wos">CHRONIC GRANULOMATOUS-DISEASE</api:keyword><api:keyword origin="record-data" source="wos">GENE-TRANSFER</api:keyword><api:keyword origin="record-data" source="wos">BONE-MARROW</api:keyword><api:keyword origin="record-data" source="wos">MEDIATED EXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">NADPH OXIDASE</api:keyword><api:keyword origin="record-data" source="wos">CELLS</api:keyword><api:keyword origin="record-data" source="wos">RECONSTITUTION</api:keyword><api:keyword origin="record-data" source="wos">ELEMENTS</api:keyword><api:keyword origin="record-data" source="wos">VECTORS</api:keyword><api:keyword origin="record-data" source="wos">REGION</api:keyword><api:keyword scheme="for" origin="issn-inferred">1102 Cardiorespiratory Medicine and Haematology</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Immunology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3201 Cardiovascular medicine and haematology</api:keyword></api:keywords></api:all-labels><api:journal issn="0390-6078" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/955541" title="Haematologica"><api:records><api:record source-name="summary"><api:title>Haematologica</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1000/relationships"/></api:object></api:result></api:response>